
EUDAMED Mandatory Registration and the Dual Registration Guide with ÜTS
As of 28 May 2026, the mandatory EUDAMED modules, who registers, the position of a manufacturer established in Turkey, and the ÜTS and EUDAMED dual registration flow. A Medex ÜTS guide.
Your firm has been registered in ÜTS for years, your devices are in "Registered" status, and now a customer or a notified body asks you for an SRN. No such number is produced on the ÜTS screens, and your ÜTS firm number does not meet this request. The reason is simple: being registered in ÜTS does not make you registered in EUDAMED, and being registered in EUDAMED does not make you registered in ÜTS. The two systems are run by different authorities, produce different numbers and create different obligations.
This page draws the boundaries of dual registration: which modules of EUDAMED are mandatory as of today, what the entry into force on the Türkiye side depends on, who is obliged to register, how the SRN comes into being, and at which points the two systems touch and at which they stay separate. The sources are the Medical Device Regulation (Tıbbi Cihaz Yönetmeliği) published in the Official Gazette No. 31499 (bis) of 2/6/2021, the Manual on Registration Procedures of Medical Devices in the Product Tracking System (Tıbbi Cihazların Ürün Takip Sistemine Kayıt Süreçlerine İlişkin Kılavuz) and the European Commission's decision on the functionality of the EUDAMED modules.
EUDAMED is not a single database but the name of seven electronic systems
Article 33(1) of the Medical Device Regulation defines EUDAMED as the European database on medical devices set up and managed by the Commission; point (a) of the same paragraph states its purpose as informing the public about devices placed on the market, certificates issued by notified bodies and economic operators, and point (b) as facilitating the unique identification and traceability of devices.
Paragraph 2 of the same article lists the electronic systems EUDAMED contains: point (a) the system on registration of devices referred to in Article 29(4), point (b) the UDI database in Article 28, point (c) the system on registration of economic operators in Article 30, point (ç) the system on notified bodies and certificates in Article 57, point (d) the system on clinical investigations in Article 73, point (e) the system on vigilance and post-market surveillance in Article 89, and point (f) the system on market surveillance in Article 97.
This distinction has a practical consequence: the sentence "EUDAMED has become mandatory" is incomplete on its own. The obligation arises module by module, and each module has its own start date.
Four modules became mandatory on 28 May 2026
The European Commission made its notice on the functionality of certain electronic systems in EUDAMED, and on their meeting the functional specifications, by Decision (EU) 2025/2371 of 26 November 2025, and this Decision was published in the Official Journal of the European Union on 27 November 2025. Article 1 of the Decision lists the four systems declared functional: the system on registration of economic operators referred to in Article 30 of Regulation (EU) 2017/745, the UDI database and the system on registration of devices in Articles 28 and 29, the system on notified bodies and certificates in Article 57, and the system on market surveillance in Article 100.
The Commission's own announcement dates the result: following the six-month transition period triggered by the publication, use of these first four modules has been mandatory from 28 May 2026. That date has passed as of today; so these modules are no longer in the voluntary-use stage.
The date in the page title is therefore correct, but misleading on its own. 28 May 2026 is not the date on which the whole of EUDAMED became mandatory, but the date on which four modules did.
The remaining two modules are still not mandatory
According to the Commission's general information on EUDAMED, the post-market surveillance and vigilance module and the clinical investigations and performance studies module have not yet been opened for mandatory use; for these two modules the Commission will publish a separate functionality notice.
The Regulation reflects this wait in its own entry-into-force provision. Article 111(1)(a) of the Medical Device Regulation states that, as regards the obligations and requirements associated with each of the electronic systems referred to in Article 33(2), including the provisions of Articles 29, 31 and 32, Article 84(2), Articles 85 and 86 and Article 88, they will enter into force 6 months after the date of publication in the Official Journal of the European Union of the Commission's notice that the relevant electronic system is functional and meets the functional specifications.
Transitional Article 1(12) of the same Regulation prevents a gap in the meantime: the provisions of the repealed Medical Device Regulation and Active Implantable Medical Devices Regulation on vigilance reporting, clinical investigations, registration of devices and economic operators, and certificate notifications continue to apply until the application date referred to in Article 111(1)(a).
In Türkiye, entry into force is tied to the same notice
The provision of Article 111 above ties the start of the obligation in Türkiye directly to the publication date of the Commission's notice. Since the notice for the first four systems was published on 27 November 2025, for the obligations associated with those systems the six-month period expired at the end of May 2026. The Commission has announced this date as 28 May 2026.
This calculation comes from the text of the Regulation; how the Agency carries out the implementation, and by which announcement, is a separate matter. The current state of the steps on the system side (such as which screen opens when, and from which channel which information is requested) needs to be confirmed from the Agency's own announcements. This page conveys what the Regulation and Commission sources say; it does not predict the Agency's administrative practice.
A separate and longer period is allowed for entering device data
Actor registration and device registration are not on the same timetable. Transitional Article 1(17)(a) of the Medical Device Regulation states that manufacturers will ensure that the information required to be entered into EUDAMED under Article 29 is entered into the system referred to in points (a) and (b) of Article 33(2) within at most 12 months from the date of publication of the notice. Sub-point (1) of the same point covers devices for which the manufacturer has carried out a conformity assessment under Article 52, other than custom-made devices; sub-point (2) covers devices placed on the market under points (a), (b) or (c) of transitional Article 1(5) and not yet registered in EUDAMED.
Point (b) of the same paragraph gives notified bodies a period of 18 months: within at most 18 months from the date of publication of the notice relating to the electronic system on certificates, the information required to be entered into EUDAMED under Article 56(5) is entered and, for the devices in sub-point (1) of point (a), only the latest relevant certificate and the notified body's subsequent decisions on that certificate are entered.
Since the publication date of the notice is 27 November 2025, the 12-month period for manufacturers expires in November 2026 and the 18-month period for notified bodies in May 2027. This is a calculation from the text of the Regulation; for the exact day it is advisable to look at the Agency's announcements.
Who is obliged to register
Article 31(1) of the Medical Device Regulation lists those under the obligation: before placing a device other than a custom-made device on the market, manufacturers, authorised representatives and importers not already registered under this Article shall enter the information referred to in section 1 of Part A of Annex VI into the electronic system in Article 30. The same paragraph also sets a sequence rule: where the conformity assessment procedure requires the involvement of a notified body under Article 52, this information is entered into the system before applying to the notified body.
The importer's role is also defined separately. Article 30(2) of the Medical Device Regulation states that importers will, within 2 weeks of a device being placed on the market, verify that the manufacturer or authorised representative has entered the relevant information in the system, inform the relevant party if the information is missing or incorrect, and add their own details to the relevant entries.
The authorised representative's obligation is also written directly. Article 11(3)(c) of the Medical Device Regulation requires the authorised representative to comply with the registration obligations in Article 31 and to verify that the manufacturer has complied with the registration obligations in Articles 27 and 29.
On the device side, too, the manufacturer has its own obligation. Article 29(4) of the Medical Device Regulation states that, before placing a device other than a custom-made device on the market, the manufacturer will enter into EUDAMED the information referred to in section 2 of Part A of Annex VI, or confirm it if already entered, and will subsequently keep this information up to date.
A manufacturer established in Türkiye cannot appoint an EU authorised representative
This is the question Turkish manufacturers ask most often. Article 11(1) of the Medical Device Regulation states that where the manufacturer is not established in Türkiye or in an EU member state, the device can be placed on the market only if the manufacturer appoints an authorised representative. So being established in Türkiye already meets the condition this paragraph seeks.
The Manual writes the same result through the ÜTS screen. Article 12(7)(d) of the Manual states that manufacturers established in an EU member state or in Türkiye will not appoint an EU authorised representative; the EU authorised representative requirement exists only for manufacturers not established in an EU member state or in Türkiye. Article 11(2)(b)(1) of the Manual, with reference to Article 11(1) of the MDR and Article 12(1) of the IVDR, states that manufacturers established outside the EU member states and Türkiye are obliged to appoint an authorised representative from Türkiye or from one of the EU member states in order to supply devices to the EU market.
The conclusion is this: for a manufacturer established in Türkiye, the EUDAMED obligation arises directly, in the capacity of manufacturer under Article 31, not through an authorised representative. If you are the Türkiye authorised representative of a manufacturer established outside Türkiye, the registration obligation lies with you under Article 11(3)(c).
The SRN is generated by EUDAMED and communicated by the Agency
Article 4(1)(rr) of the Manual gives the definition: the Single Registration Number (SRN) is the single registration number generated by EUDAMED to be allocated to the manufacturer, authorised representative or importer.
How the number comes into being is explained by Article 30(1) of the Medical Device Regulation: the electronic system in question is set up and managed by the Commission to create the single registration number referred to in Article 31(2) and to collect and process the information necessary to identify the manufacturer and, where applicable, the authorised representative and the importer. The same paragraph also states that the Agency may introduce additional provisions regarding the registration of economic operators of devices made available on the domestic market, while keeping the provisions of the Regulation.
The number reaches the firm through a verification step. Article 31(2) of the Medical Device Regulation states that, after verifying the data entered under paragraph 1, the Agency will communicate the single registration number obtained from the electronic system in Article 30 to the manufacturer, authorised representative or importer. Paragraph 6 of the same article states that the Agency will verify the confirmed data referred to in section 1 of Part A of Annex VI.
What the SRN is for once obtained is also written. Paragraph 3 of the same article states that the manufacturer will use the single registration number when applying to a notified body for conformity assessment and when accessing EUDAMED to fulfil its obligations under Article 29.
The SRN is not a number obtained once and forgotten
The post-registration maintenance obligations are listed in the Regulation. Article 31(4) of the Medical Device Regulation states that economic operators will update the data in the electronic system within 1 week of any change to the information referred to in paragraph 1.
Paragraph 5 of the same article imposes a regular confirmation obligation: economic operators confirm the accuracy of the data within 1 year of its submission and every 2 years thereafter; if this is not done within 6 months of the end of those periods, the Agency may take appropriate corrective measures until the economic operator complies with this obligation.
Paragraph 7 of the same article also carries a warning: the data entered into the electronic system under paragraph 1 become publicly available. Your address, title and contact details become visible to the public; this level of public access is not foreseen in ÜTS.
The ÜTS counterpart of the SRN is a field name, not a record
This is the first point where the two systems touch. Article 7(2)(ç) of the Manual states that, if one has been issued, the manufacturer's Single Registration Number (SRN) will be in the EU certificate and will be entered in the "Single Identification No" ("Münferit Kimlik No") field in ÜTS. Article 11(2)(c) of the Manual repeats the same rule for the EU declaration of conformity.
The words "if one has been issued" in both provisions are important: the Manual does not make the SRN an unconditional requirement for an ÜTS document record; it asks for it to be entered in the relevant field if it is in the document. So ÜTS does not read this field from EUDAMED; it expects from you what is written in the document, and looks for what you enter to be the same as the information in the document.
EUDAMED can also be used as a source of evidence in an ÜTS application
In some cases the Manual treats EUDAMED as a verification channel alternative to the apostille and notary chain. Article 8(1)(e) of the Manual states that, provided that the certificate has been uploaded to EUDAMED by the notified body with all its current and valid pages and can be accessed and verified in EUDAMED with all its pages, the original, if the certificate is e-signed, or the Turkish notary-certified copy, if it is not e-signed, may be uploaded in the "Original Document" field. Article 8(3)(f) repeats this possibility for a second application scenario.
There is a similar facility for the authorised representative document. Article 12(7)(b) of the Manual states that the agreement or authorisation document between the manufacturer and the EU authorised representative will be uploaded in the "Authorisation Document" ("Yetki Belgesi") field; alternatively, a printout of the actor screen from the EUDAMED website that clearly shows the relevant manufacturer and the EU authorised representative information may be uploaded. Sub-point (1) of point (c) of the same paragraph states that when this printout is uploaded, a Turkish translation by a sworn translator is not required.
The common language of the two systems is the Basic UDI-DI and EMDN
Article 27(5)(c)(2) of the Manual defines the Basic UDI-DI as the main key, in EUDAMED and in ÜTS and the related documents, linking devices of the same manufacturer that have the same intended purpose, risk class and essential design and manufacturing characteristics. Article 30(5)(c) of the Manual gives the same definition on the IVDR side.
There is a common ground on the terminology side too. Article 27(4)(ç)(2) of the Manual states that EMDN is the terminology to be used when devices are registered in the EUDAMED database and in ÜTS. The explanations in Annex-22 of the Manual state that EMDN is intended to support the EUDAMED functioning relating to medical devices under Article 26 of the MDR and Article 23 of the IVDR.
These two fields are where the two systems speak at the data level. But speaking does not mean feeding each other: you enter the same Basic UDI-DI into both EUDAMED and ÜTS yourself.
What stays separate: firm registration, legal basis and number
The Regulation expressly accepts the duality. Article 34(1) of the Medical Device Regulation states that, without prejudice to the EUDAMED-related obligations set out in the Regulation, economic operators, notified bodies, healthcare institutions, healthcare professionals and other relevant persons established in Türkiye will fulfil their obligations relating to the national product tracking system (ÜTS). Paragraph 2 of the same article states that the obligations relating to ÜTS will be determined by regulations published by the Agency. The words "without prejudice" show that the two obligations do not replace each other.
The source of firm registration is also different. Article 5(2) of the Manual states that firm registrations in ÜTS will be made on a MERSİS or VEDOP basis, that if a firm has both a MERSİS and a VEDOP number the transaction will be carried out on the MERSİS number, and that firm registration transactions of pharmacies will be carried out on an EBS basis. Actor registration in EUDAMED, on the other hand, is made through the electronic system in Article 30 of the Medical Device Regulation and its output is the SRN. A MERSİS number does not produce an SRN; nor does an SRN create an ÜTS firm registration.
Public access is also different. While Article 31(7) of the Medical Device Regulation makes EUDAMED actor data publicly available, a separate channel is defined for the summary of safety and clinical performance: Article 32(1)(b) of the same Regulation states that the summary will be made publicly available through EUDAMED, and point (c) states that the notified body that validates the summary will upload it to EUDAMED and that the manufacturer will state on the label or in the instructions for use where the summary can be found. This document is uploaded to EUDAMED, not to ÜTS.
What we do on dual registration, and which side the firm runs
MEDx Kurumsal Danışmanlık manages the points where the two systems intersect, within medical device ÜTS registration consultancy. The concrete outputs are:
Obligation map: Determining your firm's capacity under Article 31 of the Medical Device Regulation (manufacturer, authorised representative, importer) and listing the registration obligations that follow from it. Document–SRN consistency: Matching the SRN information in the EU certificate and the EU declaration of conformity with the ÜTS "Single Identification No" field under Article 7(2)(ç) and Article 11(2)(c) of the Manual. Basic UDI-DI and EMDN matching: Making sure the key data entered into the two systems are the same and, where there is a difference, preparing the correction list to be sent to the manufacturer. Evidence through EUDAMED output: Using the facilities in Article 8(1)(e) and Article 12(7)(b) of the Manual where appropriate, and avoiding unnecessary apostille/translation burden. Calendar tracking: Monitoring the 12- and 18-month periods in transitional Article 1(17) of the Medical Device Regulation for your device portfolio.
What we cannot do is clear too. EUDAMED is a system run by the European Commission; the Agency does not generate the SRN, but communicates it after verification under Article 31(2) of the Medical Device Regulation. The accuracy and currency of the data are the economic operator's responsibility under paragraphs 4 and 5 of the same article; a consultant cannot take on this confirmation on the firm's behalf. The summary of safety and clinical performance is uploaded by the notified body under Article 32(1)(c). The manufacturer obtains the device's Basic UDI-DI from the issuing entity. It is in any case in the firm's interest to confirm current announcements on the Agency's administrative practice.
The way of working is this: your firm assigns us a user authorization from its own ÜTS firm page, we create the ÜTS records with the "Medical Device Registration Operator" ("Tıbbi Cihaz Kayıt Elemanı") authorization, and the person who electronically signs the application remains your firm's signatory. The actor account on the EUDAMED side is your firm's own account, and responsibility for that account stays with your firm.
